Relieves apprehension. ANDA 83312, held by Hikma. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 83312 (Promethazine Hydrochloride), held by Hikma, was first approved by FDA on Sep 19, 1973, with 20 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Promethazine hydrochloride injection is indicated for the following conditions: Amelioration of allergic reactions to blood or plasma. In anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. For other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. For sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. Active treatment of motion sickness. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 19, 1973 | Original application | Approved | None posted |
| Promethazine Hydrochloride25MG/ML · injectable;injection | Promethazine Hydrochloride | RxReference drug |
| Promethazine Hydrochloride50MG/ML · injectable;injection | Promethazine Hydrochloride | RxReference drug |
| Jun 24, 2025 | Supplement 64Labeling · Standard review | Approved | None posted |
| Dec 27, 2023 | Supplement 61Labeling · Standard review | Approved | None posted |
| Nov 19, 2009 | Supplement 45Labeling | Approved | None posted |
| Mar 13, 2006 | Supplement 41Labeling | Approved | None posted |
| Jun 21, 2005 | Supplement 38Labeling | Approved | None posted |
| Apr 19, 2004 | Supplement 32Labeling | Approved | None posted |
| Apr 19, 2004 | Supplement 35Labeling | Approved | None posted |
| Nov 27, 2002 | Supplement 29Manufacturing | Approved | None posted |
| Nov 27, 2002 | Supplement 30Labeling | Approved | None posted |
| Mar 12, 2002 | Supplement 28Manufacturing | Approved | None posted |
| Aug 9, 2001 | Supplement 27Labeling | Approved | None posted |
| Nov 19, 1999 | Supplement 26Manufacturing | Approved | None posted |
| Feb 11, 1999 | Supplement 25Manufacturing | Approved | None posted |
| Dec 27, 1994 | Supplement 24Manufacturing | Approved | None posted |
| Jun 16, 1993 | Supplement 23Manufacturing | Approved | None posted |
| Oct 30, 1992 | Supplement 22Manufacturing | Approved | None posted |
| Mar 12, 1992 | Supplement 21Manufacturing | Approved | None posted |
| Nov 9, 1990 | Supplement 20Labeling | Approved | None posted |
| Aug 23, 1990 | Supplement 19Labeling | Approved | None posted |
| Mar 30, 1990 | Supplement 18Manufacturing | Approved | None posted |
| Sep 19, 1973 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters